NeurAxon Pharma Competitors and Similar CompaniesClear all
NeurAxon Pharma's competitors and similar companies include WuXi AppTec, Brii Biosciences, Eagle Pharmaceuticals and AiCuris.
 WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. |  Brii Biosciences Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses. |  Eagle Pharmaceuticals Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas. |  AiCuris AiCuris is a pharmaceutical company focusing on the discovery, research, and development of antiviral and antibacterial agents. | ||
Founding Date | Founding Date 2004 | Founding Date 2000 | Founding Date 2018 | Founding Date 2007 | Founding Date 2006 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Mississauga, CA HQ | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations CN HQ Beijing, CN Durham, US San Francisco, US San Mateo, US | Locations Woodcliff Lake, US HQ Chicago, US | Locations Wuppertal, DE HQ Borken, DE |
Employees | Employees 4 | Employees 39,414 | Employees 8510% decrease | Employees 10813% increase | Employees 731% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 20.7 b | Valuation ($) N/A | Valuation ($) 5.2 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $316.6m (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥23.8b (FY, 2025) | Cost of goods N/A | Cost of goods $85.5m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥21.3b (FY, 2025) | Gross profit N/A | Gross profit $231.2m (FY, 2022) | Gross profit N/A |
Net income | Net income N/A | Net income ¥19.3b (FY, 2025) | Net income N/A | Net income $35.6m (FY, 2022) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 782.2k (almost 14 years ago) | Latest funding round N/A | Latest funding round $ 155m (about 5 years ago) | Latest funding round N/A | Latest funding round $ 74.8m (about 16 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 902.6m | Total funding raised $ 415m | Total funding raised $ 12.3m | Total funding raised $ 74.8m |
For sources of this data, please see the company profile
View Company Profiles
WuXi AppTec
HQ
Shanghai, CN
Employees
39,414
WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production.
View companyBrii Biosciences
HQ
CN
Employees
85↓ 10% decrease
Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses.
View companyEagle Pharmaceuticals
HQ
Woodcliff Lake, US
Employees
108↑ 13% increase
Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas.
View companyAiCuris
HQ
Wuppertal, DE
Employees
73↑ 1% increase
AiCuris is a pharmaceutical company focusing on the discovery, research, and development of antiviral and antibacterial agents.
View company